CompoAtlas

DXN Mycove G Powder

DXN Mycove G Powder : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Morus microphyllaMorus microphylla[0.7gm;5gm]Not identified
Apium graveolensApium graveolens[0.35gm;5gm]Not identified
Morinda citrifoliaMorinda citrifolia[0.35gm;5gm]Not identified
Cymbopogon citratusCymbopogon citratus[0.2gm;5gm]Not identified
Zingiber officinaleZingiber officinale[0.2gm;5gm]Not identified
Citrus aurantiifoliaCitrus aurantiifolia[0.15gm;5gm]Not identified
Zea maysZea mays[0.15gm;5gm]Not identified
Citrus sinensisCitrus sinensis[0.15gm;5gm]Not identified
Camellia sinensisCamellia sinensis[0.15gm;5gm]Not identified
Syzygium aromaticumSyzygium aromaticum[0.025gm;5gm]Not identified
Cinnamomum zeylanicumCinnamomum zeylanicum[0.025gm;5gm]Not identified
Illicium verumIllicium verum[0.025gm;5gm]Not identified
Plantago ovataPlantago ovata[1gm;5gm]Not identified
Hypsizygus ulmariusHypsizygus ulmarius[0.20gm;5gm]Not identified
Schizophyllum communeSchizophyllum commune[0.15gm;5gm]Not identified
Calocybe gambosaCalocybe gambosa[0.20gm;5gm]Not identified
Lentinus edodesLentinus edodes[0.20gm;5gm]Not identified
PLEUROTUS PULMONARIUSPLEUROTUS PULMONARIUS[0.20gm;5gm]Not identified
SPIRULINA PLATENSISSPIRULINA PLATENSIS[0.15gm;5gm]Not identified
Hericium erinaceusHericium erinaceus[0.20gm;5gm]Not identified
LYOPHYLLUM DECASTESLYOPHYLLUM DECASTES[0.20gm;5gm]Not identified
CITRI RETICULATAECITRI RETICULATAE[0.025gm;5gm]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL14125094T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
DXN PHARMACEUTICAL SDN. BHD.
Manufacturer
DXN PHARMACEUTICAL SDN. BHD.
Registration period starting
2024-12-25
Published validity end
2029-12-25

Original register data

View published fields and their variants
Active ingredients
Morus microphylla[0.7gm;5gm],Apium graveolens[0.35gm;5gm],Morinda citrifolia[0.35gm;5gm],Cymbopogon citratus[0.2gm;5gm],Zingiber officinale[0.2gm;5gm],Citrus aurantiifolia[0.15gm;5gm],Zea mays[0.15gm;5gm],Citrus sinensis[0.15gm;5gm],Camellia sinensis[0.15gm;5gm],Syzygium aromaticum[0.025gm;5gm],Cinnamomum zeylanicum[0.025gm;5gm],Illicium verum[0.025gm;5gm],Plantago ovata[1gm;5gm],Hypsizygus ulmarius[0.20gm;5gm],Schizophyllum commune[0.15gm;5gm],Calocybe gambosa[0.20gm;5gm],Lentinus edodes[0.20gm;5gm],PLEUROTUS PULMONARIUS[0.20gm;5gm],SPIRULINA PLATENSIS[0.15gm;5gm],Hericium erinaceus[0.20gm;5gm],LYOPHYLLUM DECASTES[0.20gm;5gm],CITRI RETICULATAE[0.025gm;5gm]
Valid until
2029-12-25
Registration date
2024-12-25
Published description
NATURAL PRODUCT
Licence holder
DXN PHARMACEUTICAL SDN. BHD.
Producer
DXN PHARMACEUTICAL SDN. BHD.
Published name
DXN Mycove G Powder
Published reference
201309202013T
Registration number
MAL14125094T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL14125094T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Zingiber officinale
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

  • SPIRULINA PLATENSIS
    Read the warning, when it applies and the studies cited

    Spirulina

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Allergic rhinitis.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 28 March 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “DXN Mycove G Powder”, https://compoatlas.com/en/supplements/malaysia/MAL14125094T-dxn-mycove-g-powder, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line